Astrazeneca (AZN) Profit Margin History
Historical gross, operating and net quarterly profit margin for Astrazeneca (AZN) over the last 10 years. The current net profit margin for Astrazeneca as of October 20, 2017 is 17.8%.
|Medical||Large Cap Pharmaceutical||$87.652B||$23.002B|
|AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.|